EU plans new Health Authority
Recommendation

10/11 February 2026
Heidelberg, Germany
Medicinal Products/Drugs meet Medical Devices
The European Commission is planning to create a new EU Health Emergency Preparedness and Response Authority (HERA). For this purpose, the Commission has published a so-called Inception Impact Assessment and opened a feedback procedure.
As the name suggests, HERA's primary tasks are to coordinate measures to deal with health emergencies at EU level, monitor development capacities and identify potential problems. Emergency tasks are to include, for example:
- Coordinating between relevant Union agencies, national authorities and external stakeholders (e.g. industry, academic institutions, research organisations).
- Monitoring development capacities
- Promoting advanced research, innovation and development of relevant technologies and countermeasures for anticipated cross-border health threats
- Build flexible and scalable EU production capacity for the development of crisis-relevant countermeasures (including crisis-relevant raw materials)
- Competence for financing and procurement in case of need, including a logistical infrastructure (storage and distribution)
The feedback process is open until 24 February 2021, after which there will be a public consultation. Adoption by the European Commission is planned for the last quarter of 2021. For more information, please visit the website of the European Commission.
Related GMP News
04.02.2026When Training Falls Short: FDA Findings on GMP Training Deficiencies in 2025
27.01.2026New Ph. Eur. Publication Schedule
21.01.2026EU Pharma Package: EMA with single Point of Information
14.01.2026European QP Association Developments September through December 2025
14.01.2026Could a change of ownership be relevant to GMP?
07.01.2026Is QP Certification required when Products do not enter EU Territory?


